11/05/2024 | Press release | Distributed by Public on 11/05/2024 11:27
Class | Cost of a $10,000 investment | Cost paid as a percentage of a $10,000 investment |
Class A |
$
46
|
0.86
%
|
Fund net assets |
$
1,515,137,746
|
Total number of portfolio holdings | 57 |
Portfolio turnover for the reporting period | 29% |
Microsoft Corp. |
7.6
%
|
NVIDIA Corp. |
6.7
%
|
Apple, Inc. |
6.3
%
|
Alphabet, Inc., Class C |
4.9
%
|
Amazon.com, Inc. |
4.6
%
|
Meta Platforms, Inc., Class A |
3.5
%
|
Eli Lilly & Co. |
2.6
%
|
Exxon Mobil Corp. |
2.5
%
|
UnitedHealth Group, Inc. |
2.4
%
|
MasterCard, Inc., Class A |
2.4
%
|
Class | Cost of a $10,000 investment | Cost paid as a percentage of a $10,000 investment |
Advisor Class |
$
32
|
0.61
%
|
Fund net assets |
$
1,515,137,746
|
Total number of portfolio holdings | 57 |
Portfolio turnover for the reporting period | 29% |
Microsoft Corp. |
7.6
%
|
NVIDIA Corp. |
6.7
%
|
Apple, Inc. |
6.3
%
|
Alphabet, Inc., Class C |
4.9
%
|
Amazon.com, Inc. |
4.6
%
|
Meta Platforms, Inc., Class A |
3.5
%
|
Eli Lilly & Co. |
2.6
%
|
Exxon Mobil Corp. |
2.5
%
|
UnitedHealth Group, Inc. |
2.4
%
|
MasterCard, Inc., Class A |
2.4
%
|
Class | Cost of a $10,000 investment | Cost paid as a percentage of a $10,000 investment |
Class C |
$
85
|
1.60
%
|
Fund net assets |
$
1,515,137,746
|
Total number of portfolio holdings | 57 |
Portfolio turnover for the reporting period | 29% |
Microsoft Corp. |
7.6
%
|
NVIDIA Corp. |
6.7
%
|
Apple, Inc. |
6.3
%
|
Alphabet, Inc., Class C |
4.9
%
|
Amazon.com, Inc. |
4.6
%
|
Meta Platforms, Inc., Class A |
3.5
%
|
Eli Lilly & Co. |
2.6
%
|
Exxon Mobil Corp. |
2.5
%
|
UnitedHealth Group, Inc. |
2.4
%
|
MasterCard, Inc., Class A |
2.4
%
|
Class | Cost of a $10,000 investment | Cost paid as a percentage of a $10,000 investment |
Institutional Class |
$
32
|
0.61
%
|
Fund net assets |
$
1,515,137,746
|
Total number of portfolio holdings | 57 |
Portfolio turnover for the reporting period | 29% |
Microsoft Corp. |
7.6
%
|
NVIDIA Corp. |
6.7
%
|
Apple, Inc. |
6.3
%
|
Alphabet, Inc., Class C |
4.9
%
|
Amazon.com, Inc. |
4.6
%
|
Meta Platforms, Inc., Class A |
3.5
%
|
Eli Lilly & Co. |
2.6
%
|
Exxon Mobil Corp. |
2.5
%
|
UnitedHealth Group, Inc. |
2.4
%
|
MasterCard, Inc., Class A |
2.4
%
|
Class | Cost of a $10,000 investment | Cost paid as a percentage of a $10,000 investment |
Institutional 2 Class |
$
29
|
0.55
%
|
Fund net assets |
$
1,515,137,746
|
Total number of portfolio holdings | 57 |
Portfolio turnover for the reporting period | 29% |
Microsoft Corp. |
7.6
%
|
NVIDIA Corp. |
6.7
%
|
Apple, Inc. |
6.3
%
|
Alphabet, Inc., Class C |
4.9
%
|
Amazon.com, Inc. |
4.6
%
|
Meta Platforms, Inc., Class A |
3.5
%
|
Eli Lilly & Co. |
2.6
%
|
Exxon Mobil Corp. |
2.5
%
|
UnitedHealth Group, Inc. |
2.4
%
|
MasterCard, Inc., Class A |
2.4
%
|
Class | Cost of a $10,000 investment | Cost paid as a percentage of a $10,000 investment |
Institutional 3 Class |
$
27
|
0.50
%
|
Fund net assets |
$
1,515,137,746
|
Total number of portfolio holdings | 57 |
Portfolio turnover for the reporting period | 29% |
Microsoft Corp. |
7.6
%
|
NVIDIA Corp. |
6.7
%
|
Apple, Inc. |
6.3
%
|
Alphabet, Inc., Class C |
4.9
%
|
Amazon.com, Inc. |
4.6
%
|
Meta Platforms, Inc., Class A |
3.5
%
|
Eli Lilly & Co. |
2.6
%
|
Exxon Mobil Corp. |
2.5
%
|
UnitedHealth Group, Inc. |
2.4
%
|
MasterCard, Inc., Class A |
2.4
%
|
Item 2. Code of Ethics.
Not applicable.
Item 3. Audit Committee Financial Expert.
Not applicable.
Item 4. Principal Accountant Fees and Services.
Not applicable.
Item 5. Audit Committee of Listed Registrants.
Not applicable.
Item 6. Investments.
(a) The registrant's "Schedule I - Investments in securities of unaffiliated issuers" (as set forth in 17 CFR 210.12-12) is included in Item 7 of this Form N-CSR.
(b) Not applicable.
Item 7. Financial Statements and Financial Highlights for Open-End Management Investment Companies.
Not FDIC or NCUA Insured
|
No Financial Institution Guarantee
|
May Lose Value
|
Portfolio of Investments
|
3
|
Statement of Assets and Liabilities
|
7
|
Statement of Operations
|
9
|
Statement of Changes in Net Assets
|
10
|
Financial Highlights
|
12
|
Notes to Financial Statements
|
16
|
Approval of Management Agreement
|
27
|
Common Stocks 99.2%
|
||
Issuer
|
Shares
|
Value ($)
|
Communication Services 8.3%
|
||
Interactive Media & Services 8.3%
|
||
Alphabet, Inc., Class C
|
446,286
|
73,686,282
|
Meta Platforms, Inc., Class A
|
100,187
|
52,228,485
|
Total
|
125,914,767
|
|
Total Communication Services
|
125,914,767
|
|
Consumer Discretionary 8.8%
|
||
Automobile Components 1.1%
|
||
Aptiv PLC(a)
|
245,463
|
17,557,968
|
Automobiles 0.3%
|
||
Tesla, Inc.(a)
|
18,369
|
3,932,987
|
Broadline Retail 4.6%
|
||
Amazon.com, Inc.(a),(b)
|
393,286
|
70,201,551
|
Hotels, Restaurants & Leisure 1.1%
|
||
Hilton Worldwide Holdings, Inc.
|
78,260
|
17,189,026
|
Specialty Retail 1.7%
|
||
TJX Companies, Inc. (The)
|
216,029
|
25,333,721
|
Total Consumer Discretionary
|
134,215,253
|
|
Consumer Staples 6.1%
|
||
Beverages 1.7%
|
||
Coca-Cola Co. (The)
|
357,364
|
25,898,169
|
Consumer Staples Distribution & Retail 2.2%
|
||
Walmart, Inc.
|
428,072
|
33,060,001
|
Household Products 2.2%
|
||
Procter & Gamble Co. (The)
|
196,991
|
33,791,836
|
Total Consumer Staples
|
92,750,006
|
|
Energy 3.9%
|
||
Oil, Gas & Consumable Fuels 3.9%
|
||
EOG Resources, Inc.
|
169,411
|
21,823,525
|
Exxon Mobil Corp.
|
319,327
|
37,661,426
|
Total
|
59,484,951
|
|
Total Energy
|
59,484,951
|
Common Stocks (continued)
|
||
Issuer
|
Shares
|
Value ($)
|
Financials 10.6%
|
||
Banks 3.7%
|
||
Bank of America Corp.
|
832,913
|
33,941,205
|
Citigroup, Inc.
|
345,672
|
21,652,894
|
Total
|
55,594,099
|
|
Capital Markets 1.7%
|
||
BlackRock, Inc.
|
28,541
|
25,738,559
|
Financial Services 2.3%
|
||
MasterCard, Inc., Class A
|
73,550
|
35,549,657
|
Insurance 2.9%
|
||
Chubb Ltd.
|
73,684
|
20,939,519
|
Marsh & McLennan Companies, Inc.
|
98,180
|
22,336,932
|
Total
|
43,276,451
|
|
Total Financials
|
160,158,766
|
|
Health Care 14.3%
|
||
Biotechnology 3.0%
|
||
BioMarin Pharmaceutical, Inc.(a)
|
95,230
|
8,685,928
|
Exact Sciences Corp.(a)
|
122,204
|
7,538,765
|
Insmed, Inc.(a)
|
97,978
|
7,492,378
|
Natera, Inc.(a)
|
62,941
|
7,443,403
|
Vertex Pharmaceuticals, Inc.(a)
|
29,925
|
14,839,508
|
Total
|
45,999,982
|
|
Health Care Equipment & Supplies 2.6%
|
||
Boston Scientific Corp.(a)
|
239,660
|
19,601,791
|
Intuitive Surgical, Inc.(a)
|
39,241
|
19,331,294
|
Total
|
38,933,085
|
|
Health Care Providers & Services 2.5%
|
||
UnitedHealth Group, Inc.
|
62,677
|
36,991,965
|
Life Sciences Tools & Services 1.7%
|
||
Thermo Fisher Scientific, Inc.
|
41,719
|
25,660,105
|
Pharmaceuticals 4.5%
|
||
Eli Lilly & Co.(b)
|
41,506
|
39,846,590
|
Merck & Co., Inc.
|
241,792
|
28,640,263
|
Total
|
68,486,853
|
|
Total Health Care
|
216,071,990
|
Common Stocks (continued)
|
||
Issuer
|
Shares
|
Value ($)
|
Industrials 10.1%
|
||
Aerospace & Defense 1.5%
|
||
General Dynamics Corp.
|
77,903
|
23,321,042
|
Commercial Services & Supplies 3.0%
|
||
Cintas Corp.
|
27,327
|
22,001,514
|
Republic Services, Inc.
|
110,641
|
23,036,563
|
Total
|
45,038,077
|
|
Electrical Equipment 1.3%
|
||
Eaton Corp. PLC(b)
|
64,279
|
19,729,154
|
Ground Transportation 1.7%
|
||
Union Pacific Corp.
|
102,067
|
26,138,338
|
Industrial Conglomerates 1.3%
|
||
Honeywell International, Inc.
|
94,196
|
19,584,290
|
Machinery 1.3%
|
||
Parker-Hannifin Corp.
|
32,655
|
19,599,531
|
Total Industrials
|
153,410,432
|
|
Information Technology 29.5%
|
||
Electronic Equipment, Instruments & Components 1.5%
|
||
TE Connectivity Ltd.
|
150,137
|
23,061,043
|
Semiconductors & Semiconductor Equipment 10.8%
|
||
Broadcom, Inc.
|
140,384
|
22,857,323
|
Lam Research Corp.
|
22,259
|
18,274,861
|
NVIDIA Corp.
|
854,229
|
101,969,316
|
QUALCOMM, Inc.(b)
|
117,824
|
20,654,547
|
Total
|
163,756,047
|
|
Software 10.9%
|
||
Adobe, Inc.(a)
|
46,020
|
26,434,348
|
Microsoft Corp.
|
276,976
|
115,537,769
|
Palo Alto Networks, Inc.(a)
|
61,262
|
22,220,953
|
Total
|
164,193,070
|
|
Technology Hardware, Storage & Peripherals 6.3%
|
||
Apple, Inc.
|
418,712
|
95,885,048
|
Total Information Technology
|
446,895,208
|
Common Stocks (continued)
|
||
Issuer
|
Shares
|
Value ($)
|
Real Estate 4.1%
|
||
Health Care REITs 1.1%
|
||
Healthpeak Properties, Inc.
|
753,571
|
16,789,562
|
Industrial REITs 1.5%
|
||
Prologis, Inc.
|
172,882
|
22,097,777
|
Specialized REITs 1.5%
|
||
Equinix, Inc.(b)
|
27,241
|
22,728,801
|
Total Real Estate
|
61,616,140
|
|
Utilities 3.5%
|
||
Multi-Utilities 3.5%
|
||
Ameren Corp.
|
302,193
|
24,933,944
|
DTE Energy Co.
|
222,533
|
27,821,076
|
Total
|
52,755,020
|
|
Total Utilities
|
52,755,020
|
|
Total Common Stocks
(Cost $845,038,915)
|
1,503,272,533
|
|
|
||
Exchange-Traded Equity Funds 0.1%
|
||
|
Shares
|
Value ($)
|
U.S. Large Cap 0.1%
|
||
Columbia Research Enhanced Core ETF(c)
|
46,536
|
1,555,698
|
Total Exchange-Traded Equity Funds
(Cost $1,120,587)
|
1,555,698
|
|
|
||
Money Market Funds 0.8%
|
||
|
|
|
Columbia Short-Term Cash Fund, 5.521%(c),(d)
|
11,528,447
|
11,526,141
|
Total Money Market Funds
(Cost $11,524,446)
|
11,526,141
|
|
Total Investments in Securities
(Cost: $857,683,948)
|
1,516,354,372
|
|
Other Assets & Liabilities, Net
|
(1,216,626
)
|
|
Net Assets
|
1,515,137,746
|
Call option contracts written
|
||||||||
Description
|
Counterparty
|
Trading
currency
|
Notional
amount
|
Number of
contracts
|
Exercise
price/Rate
|
Expiration
date
|
Premium
received ($)
|
Value ($)
|
Amazon.com, Inc.
|
Morgan Stanley
|
USD
|
(13,726,650
)
|
(769
)
|
195.00
|
9/20/2024
|
(73,255
)
|
(23,070
)
|
Eaton Corp PLC
|
Morgan Stanley
|
USD
|
(3,959,397
)
|
(129
)
|
320.00
|
9/20/2024
|
(31,683
)
|
(35,153
)
|
Eli Lilly & Co.
|
Morgan Stanley
|
USD
|
(7,968,166
)
|
(83
)
|
1,020.00
|
9/20/2024
|
(49,304
)
|
(36,312
)
|
Equinix, Inc.
|
Morgan Stanley
|
USD
|
(4,505,544
)
|
(54
)
|
910.00
|
9/20/2024
|
(2,618
)
|
(3,240
)
|
QUALCOMM, Inc.
|
Morgan Stanley
|
USD
|
(4,137,080
)
|
(236
)
|
190.00
|
9/20/2024
|
(40,273
)
|
(26,550
)
|
Total
|
|
|
(197,133
)
|
(124,325
)
|
(a)
|
Non-income producing investment.
|
(b)
|
This security or a portion of this security has been pledged as collateral in connection with derivative contracts.
|
(c)
|
As defined in the Investment Company Act of 1940, as amended, an affiliated company is one in which the Fund owns 5% or more of the company's outstanding voting securities, or a company which is under common ownership or control with the Fund. The value of the holdings and transactions in these affiliated companies during the period ended August 31, 2024 are as follows:
|
Affiliated issuers
|
Beginning
of period($)
|
Purchases($)
|
Sales($)
|
Net change in
unrealized
appreciation
(depreciation)($)
|
End of
period($)
|
Realized gain
(loss)($)
|
Dividends($)
|
End of
period shares
|
Columbia Research Enhanced Core ETF
|
||||||||
|
9,972,911
|
8,022,429
|
(15,462,825
)
|
(976,817
)
|
1,555,698
|
1,690,407
|
-
|
46,536
|
Columbia Short-Term Cash Fund, 5.521%
|
||||||||
|
9,104,735
|
95,548,187
|
(93,127,456
)
|
675
|
11,526,141
|
1,548
|
242,787
|
11,528,447
|
Total
|
19,077,646
|
(976,142
)
|
13,081,839
|
1,691,955
|
242,787
|
(d)
|
The rate shown is the seven-day current annualized yield at August 31, 2024.
|
USD
|
US Dollar
|
|
Level 1 ($)
|
Level 2 ($)
|
Level 3 ($)
|
Total ($)
|
Investments in Securities
|
||||
Common Stocks
|
||||
Communication Services
|
125,914,767
|
-
|
-
|
125,914,767
|
Consumer Discretionary
|
134,215,253
|
-
|
-
|
134,215,253
|
Consumer Staples
|
92,750,006
|
-
|
-
|
92,750,006
|
Energy
|
59,484,951
|
-
|
-
|
59,484,951
|
Financials
|
160,158,766
|
-
|
-
|
160,158,766
|
Health Care
|
216,071,990
|
-
|
-
|
216,071,990
|
Industrials
|
153,410,432
|
-
|
-
|
153,410,432
|
Information Technology
|
446,895,208
|
-
|
-
|
446,895,208
|
Real Estate
|
61,616,140
|
-
|
-
|
61,616,140
|
Utilities
|
52,755,020
|
-
|
-
|
52,755,020
|
Total Common Stocks
|
1,503,272,533
|
-
|
-
|
1,503,272,533
|
Exchange-Traded Equity Funds
|
1,555,698
|
-
|
-
|
1,555,698
|
Money Market Funds
|
11,526,141
|
-
|
-
|
11,526,141
|
Total Investments in Securities
|
1,516,354,372
|
-
|
-
|
1,516,354,372
|
Investments in Derivatives
|
||||
Liability
|
||||
Call Option Contracts Written
|
(124,325
)
|
-
|
-
|
(124,325
)
|
Total
|
1,516,230,047
|
-
|
-
|
1,516,230,047
|
Assets
|
|
Investments in securities, at value
|
|
Unaffiliated issuers (cost $845,038,915)
|
$1,503,272,533
|
Affiliated issuers (cost $12,645,033)
|
13,081,839
|
Cash
|
10,200
|
Receivable for:
|
|
Investments sold
|
13,400,420
|
Capital shares sold
|
299,045
|
Dividends
|
1,356,243
|
Expense reimbursement due from Investment Manager
|
8,466
|
Prepaid expenses
|
12,154
|
Other assets
|
32,422
|
Total assets
|
1,531,473,322
|
Liabilities
|
|
Option contracts written, at value (premiums received $197,133)
|
124,325
|
Payable for:
|
|
Investments purchased
|
15,108,199
|
Capital shares redeemed
|
789,729
|
Management services fees
|
29,516
|
Distribution and/or service fees
|
2,035
|
Transfer agent fees
|
64,626
|
Compensation of chief compliance officer
|
129
|
Compensation of board members
|
2,614
|
Other expenses
|
41,177
|
Deferred compensation of board members
|
173,226
|
Total liabilities
|
16,335,576
|
Net assets applicable to outstanding capital stock
|
$1,515,137,746
|
Represented by
|
|
Paid in capital
|
821,267,195
|
Total distributable earnings (loss)
|
693,870,551
|
Total - representing net assets applicable to outstanding capital stock
|
$1,515,137,746
|
Class A
|
|
Net assets
|
$262,850,239
|
Shares outstanding
|
12,078,343
|
Net asset value per share
|
$21.76
|
Maximum sales charge
|
5.75%
|
Maximum offering price per share (calculated by dividing the net asset value per share by 1.0 minus the maximum sales charge for Class A shares)
|
$23.09
|
Advisor Class
|
|
Net assets
|
$6,627,755
|
Shares outstanding
|
309,361
|
Net asset value per share
|
$21.42
|
Class C
|
|
Net assets
|
$9,469,012
|
Shares outstanding
|
498,008
|
Net asset value per share
|
$19.01
|
Institutional Class
|
|
Net assets
|
$359,348,369
|
Shares outstanding
|
16,670,353
|
Net asset value per share
|
$21.56
|
Institutional 2 Class
|
|
Net assets
|
$238,099,448
|
Shares outstanding
|
10,578,679
|
Net asset value per share
|
$22.51
|
Institutional 3 Class
|
|
Net assets
|
$638,742,923
|
Shares outstanding
|
30,246,961
|
Net asset value per share
|
$21.12
|
Net investment income
|
|
Income:
|
|
Dividends - unaffiliated issuers
|
$7,647,136
|
Dividends - affiliated issuers
|
242,787
|
Total income
|
7,889,923
|
Expenses:
|
|
Management services fees
|
5,271,155
|
Distribution and/or service fees
|
|
Class A
|
314,786
|
Class C
|
47,191
|
Transfer agent fees
|
|
Class A
|
145,742
|
Advisor Class
|
3,392
|
Class C
|
5,465
|
Institutional Class
|
198,125
|
Institutional 2 Class
|
62,987
|
Institutional 3 Class
|
16,368
|
Custodian fees
|
7,958
|
Printing and postage fees
|
18,773
|
Registration fees
|
51,043
|
Accounting services fees
|
15,609
|
Legal fees
|
11,425
|
Compensation of chief compliance officer
|
129
|
Compensation of board members
|
12,422
|
Deferred compensation of board members
|
21,126
|
Other
|
14,921
|
Total expenses
|
6,218,617
|
Fees waived or expenses reimbursed by Investment Manager and its affiliates
|
(1,825,446
)
|
Total net expenses
|
4,393,171
|
Net investment income
|
3,496,752
|
Realized and unrealized gain (loss) - net
|
|
Net realized gain (loss) on:
|
|
Investments - unaffiliated issuers
|
36,607,508
|
Investments - affiliated issuers
|
1,691,955
|
Option contracts written
|
(956,648
)
|
Net realized gain
|
37,342,815
|
Net change in unrealized appreciation (depreciation) on:
|
|
Investments - unaffiliated issuers
|
120,843,780
|
Investments - affiliated issuers
|
(976,142
)
|
Option contracts written
|
118,193
|
Net change in unrealized appreciation (depreciation)
|
119,985,831
|
Net realized and unrealized gain
|
157,328,646
|
Net increase in net assets resulting from operations
|
$160,825,398
|
|
Six Months Ended
August 31, 2024
(Unaudited)
|
Year Ended
February 29, 2024
|
Operations
|
||
Net investment income
|
$3,496,752
|
$12,646,725
|
Net realized gain
|
37,342,815
|
79,925,271
|
Net change in unrealized appreciation (depreciation)
|
119,985,831
|
275,837,165
|
Net increase in net assets resulting from operations
|
160,825,398
|
368,409,161
|
Distributions to shareholders
|
||
Net investment income and net realized gains
|
||
Class A
|
(7,690,274
)
|
(10,306,336
)
|
Advisor Class
|
(186,752
)
|
(159,596
)
|
Class C
|
(312,332
)
|
(401,388
)
|
Institutional Class
|
(10,660,974
)
|
(14,270,123
)
|
Institutional 2 Class
|
(6,860,287
)
|
(9,720,958
)
|
Institutional 3 Class
|
(19,885,842
)
|
(31,044,083
)
|
Total distributions to shareholders
|
(45,596,461
)
|
(65,902,484
)
|
Decrease in net assets from capital stock activity
|
(22,986,648
)
|
(90,263,770
)
|
Total increase in net assets
|
92,242,289
|
212,242,907
|
Net assets at beginning of period
|
1,422,895,457
|
1,210,652,550
|
Net assets at end of period
|
$1,515,137,746
|
$1,422,895,457
|
|
Six Months Ended
|
Year Ended
|
||
|
August 31, 2024 (Unaudited)
|
February 29, 2024
|
||
|
Shares
|
Dollars ($)
|
Shares
|
Dollars ($)
|
Capital stock activity
|
||||
Class A
|
||||
Shares sold
|
538,132
|
11,348,001
|
1,038,569
|
18,737,215
|
Distributions reinvested
|
161,124
|
3,419,055
|
244,514
|
4,431,794
|
Shares redeemed
|
(711,633
)
|
(14,914,407
)
|
(1,359,454
)
|
(24,298,197
)
|
Net decrease
|
(12,377
)
|
(147,351
)
|
(76,371
)
|
(1,129,188
)
|
Advisor Class
|
||||
Shares sold
|
108,009
|
2,209,658
|
153,881
|
2,759,470
|
Distributions reinvested
|
8,938
|
186,632
|
8,925
|
159,429
|
Shares redeemed
|
(38,536
)
|
(783,881
)
|
(58,424
)
|
(1,018,609
)
|
Net increase
|
78,411
|
1,612,409
|
104,382
|
1,900,290
|
Class C
|
||||
Shares sold
|
49,019
|
899,284
|
127,142
|
2,019,408
|
Distributions reinvested
|
15,867
|
294,650
|
23,814
|
380,405
|
Shares redeemed
|
(91,635
)
|
(1,685,747
)
|
(208,060
)
|
(3,231,873
)
|
Net decrease
|
(26,749
)
|
(491,813
)
|
(57,104
)
|
(832,060
)
|
Institutional Class
|
||||
Shares sold
|
776,191
|
15,990,794
|
2,791,170
|
50,120,795
|
Distributions reinvested
|
473,989
|
9,958,506
|
743,366
|
13,331,545
|
Shares redeemed
|
(1,055,826
)
|
(21,928,591
)
|
(3,577,223
)
|
(62,940,502
)
|
Net increase (decrease)
|
194,354
|
4,020,709
|
(42,687
)
|
511,838
|
Institutional 2 Class
|
||||
Shares sold
|
784,800
|
16,872,605
|
1,471,395
|
27,762,441
|
Distributions reinvested
|
312,827
|
6,860,287
|
519,992
|
9,720,958
|
Shares redeemed
|
(815,459
)
|
(17,585,007
)
|
(2,919,171
)
|
(54,306,403
)
|
Net increase (decrease)
|
282,168
|
6,147,885
|
(927,784
)
|
(16,823,004
)
|
Institutional 3 Class
|
||||
Shares sold
|
331,715
|
6,752,254
|
2,697,732
|
47,261,101
|
Distributions reinvested
|
889,809
|
18,312,265
|
1,642,023
|
28,865,876
|
Shares redeemed
|
(2,909,794
)
|
(59,193,006
)
|
(8,421,514
)
|
(150,018,623
)
|
Net decrease
|
(1,688,270
)
|
(34,128,487
)
|
(4,081,759
)
|
(73,891,646
)
|
Total net decrease
|
(1,172,463
)
|
(22,986,648
)
|
(5,081,323
)
|
(90,263,770
)
|
|
Net asset value,
beginning of
period
|
Net
investment
income
(loss)
|
Net
realized
and
unrealized
gain (loss)
|
Total from
investment
operations
|
Distributions
from net
investment
income
|
Distributions
from net
realized
gains
|
Total
distributions to
shareholders
|
Class A
|
|||||||
Six Months Ended 8/31/2024 (Unaudited)
|
$20.13
|
0.02
|
2.26
|
2.28
|
(0.05
)
|
(0.60
)
|
(0.65
)
|
Year Ended 2/29/2024
|
$15.99
|
0.13
|
4.88
|
5.01
|
(0.14
)
|
(0.73
)
|
(0.87
)
|
Year Ended 2/28/2023
|
$18.81
|
0.13
|
(2.03
)
|
(1.90
)
|
(0.12
)
|
(0.80
)
|
(0.92
)
|
Year Ended 2/28/2022
|
$17.28
|
0.11
|
2.88
|
2.99
|
(0.15
)
|
(1.31
)
|
(1.46
)
|
Year Ended 2/28/2021
|
$14.22
|
0.14
|
4.08
|
4.22
|
(0.21
)
|
(0.95
)
|
(1.16
)
|
Year Ended 2/29/2020
|
$13.95
|
0.24
|
0.77
|
1.01
|
(0.12
)
|
(0.62
)
|
(0.74
)
|
Advisor Class
|
|||||||
Six Months Ended 8/31/2024 (Unaudited)
|
$19.81
|
0.05
|
2.22
|
2.27
|
(0.06
)
|
(0.60
)
|
(0.66
)
|
Year Ended 2/29/2024
|
$15.74
|
0.17
|
4.81
|
4.98
|
(0.18
)
|
(0.73
)
|
(0.91
)
|
Year Ended 2/28/2023
|
$18.53
|
0.17
|
(2.00
)
|
(1.83
)
|
(0.16
)
|
(0.80
)
|
(0.96
)
|
Year Ended 2/28/2022
|
$17.04
|
0.15
|
2.84
|
2.99
|
(0.19
)
|
(1.31
)
|
(1.50
)
|
Year Ended 2/28/2021
|
$14.04
|
0.18
|
4.02
|
4.20
|
(0.25
)
|
(0.95
)
|
(1.20
)
|
Year Ended 2/29/2020
|
$13.78
|
0.26
|
0.78
|
1.04
|
(0.16
)
|
(0.62
)
|
(0.78
)
|
Class C
|
|||||||
Six Months Ended 8/31/2024 (Unaudited)
|
$17.70
|
(0.05
)
|
1.98
|
1.93
|
(0.02
)
|
(0.60
)
|
(0.62
)
|
Year Ended 2/29/2024
|
$14.17
|
(0.01
)
|
4.30
|
4.29
|
(0.03
)
|
(0.73
)
|
(0.76
)
|
Year Ended 2/28/2023
|
$16.78
|
0.01
|
(1.82
)
|
(1.81
)
|
(0.00
)(e)
|
(0.80
)
|
(0.80
)
|
Year Ended 2/28/2022
|
$15.58
|
(0.04
)
|
2.60
|
2.56
|
(0.05
)
|
(1.31
)
|
(1.36
)
|
Year Ended 2/28/2021
|
$12.92
|
0.03
|
3.69
|
3.72
|
(0.11
)
|
(0.95
)
|
(1.06
)
|
Year Ended 2/29/2020
|
$12.74
|
0.11
|
0.71
|
0.82
|
(0.02
)
|
(0.62
)
|
(0.64
)
|
Institutional Class
|
|||||||
Six Months Ended 8/31/2024 (Unaudited)
|
$19.92
|
0.05
|
2.25
|
2.30
|
(0.06
)
|
(0.60
)
|
(0.66
)
|
Year Ended 2/29/2024
|
$15.83
|
0.17
|
4.83
|
5.00
|
(0.18
)
|
(0.73
)
|
(0.91
)
|
Year Ended 2/28/2023
|
$18.63
|
0.17
|
(2.01
)
|
(1.84
)
|
(0.16
)
|
(0.80
)
|
(0.96
)
|
Year Ended 2/28/2022
|
$17.13
|
0.15
|
2.85
|
3.00
|
(0.19
)
|
(1.31
)
|
(1.50
)
|
Year Ended 2/28/2021
|
$14.10
|
0.18
|
4.05
|
4.23
|
(0.25
)
|
(0.95
)
|
(1.20
)
|
Year Ended 2/29/2020
|
$13.84
|
0.26
|
0.78
|
1.04
|
(0.16
)
|
(0.62
)
|
(0.78
)
|
Institutional 2 Class
|
|||||||
Six Months Ended 8/31/2024 (Unaudited)
|
$20.77
|
0.06
|
2.34
|
2.40
|
(0.06
)
|
(0.60
)
|
(0.66
)
|
Year Ended 2/29/2024
|
$16.47
|
0.19
|
5.03
|
5.22
|
(0.19
)
|
(0.73
)
|
(0.92
)
|
Year Ended 2/28/2023
|
$19.35
|
0.19
|
(2.10
)
|
(1.91
)
|
(0.17
)
|
(0.80
)
|
(0.97
)
|
Year Ended 2/28/2022
|
$17.73
|
0.17
|
2.97
|
3.14
|
(0.21
)
|
(1.31
)
|
(1.52
)
|
Year Ended 2/28/2021
|
$14.55
|
0.21
|
4.18
|
4.39
|
(0.26
)
|
(0.95
)
|
(1.21
)
|
Year Ended 2/29/2020
|
$14.26
|
0.29
|
0.79
|
1.08
|
(0.17
)
|
(0.62
)
|
(0.79
)
|
|
Net
asset
value,
end of
period
|
Total
return
|
Total gross
expense
ratio to
average
net assets(a)
|
Total net
expense
ratio to
average
net assets(a),(b)
|
Net investment
income (loss)
ratio to
average
net assets
|
Portfolio
turnover
|
Net
assets,
end of
period
(000's)
|
Class A
|
|||||||
Six Months Ended 8/31/2024 (Unaudited)
|
$21.76
|
11.40%
|
1.10%
|
0.86%
|
0.22%
|
29%
|
$262,850
|
Year Ended 2/29/2024
|
$20.13
|
31.98%
|
1.12%
|
0.83%
(c)
|
0.71%
|
61%
|
$243,348
|
Year Ended 2/28/2023
|
$15.99
|
(9.89%
)
|
1.12%
(d)
|
0.80%
(c),(d)
|
0.81%
|
55%
|
$194,560
|
Year Ended 2/28/2022
|
$18.81
|
17.04%
|
1.12%
(d)
|
0.79%
(c),(d)
|
0.54%
|
58%
|
$235,276
|
Year Ended 2/28/2021
|
$17.28
|
30.70%
|
1.16%
(d)
|
0.79%
(c),(d)
|
0.92%
|
64%
|
$216,047
|
Year Ended 2/29/2020
|
$14.22
|
7.30%
|
1.18%
|
0.80%
(c)
|
1.63%
|
46%
|
$155,699
|
Advisor Class
|
|||||||
Six Months Ended 8/31/2024 (Unaudited)
|
$21.42
|
11.52%
|
0.86%
|
0.61%
|
0.47%
|
29%
|
$6,628
|
Year Ended 2/29/2024
|
$19.81
|
32.35%
|
0.87%
|
0.58%
(c)
|
0.96%
|
61%
|
$4,574
|
Year Ended 2/28/2023
|
$15.74
|
(9.64%
)
|
0.88%
(d)
|
0.55%
(c),(d)
|
1.06%
|
55%
|
$1,993
|
Year Ended 2/28/2022
|
$18.53
|
17.31%
|
0.87%
(d)
|
0.54%
(c),(d)
|
0.79%
|
58%
|
$1,932
|
Year Ended 2/28/2021
|
$17.04
|
30.96%
|
0.91%
(d)
|
0.54%
(c),(d)
|
1.18%
|
64%
|
$1,678
|
Year Ended 2/29/2020
|
$14.04
|
7.58%
|
0.93%
|
0.55%
(c)
|
1.81%
|
46%
|
$3,294
|
Class C
|
|||||||
Six Months Ended 8/31/2024 (Unaudited)
|
$19.01
|
11.01%
|
1.85%
|
1.60%
|
(0.53%
)
|
29%
|
$9,469
|
Year Ended 2/29/2024
|
$17.70
|
30.91%
|
1.87%
|
1.58%
(c)
|
(0.04%
)
|
61%
|
$9,290
|
Year Ended 2/28/2023
|
$14.17
|
(10.54%
)
|
1.88%
(d)
|
1.55%
(c),(d)
|
0.06%
|
55%
|
$8,243
|
Year Ended 2/28/2022
|
$16.78
|
16.13%
|
1.87%
(d)
|
1.54%
(c),(d)
|
(0.21%
)
|
58%
|
$8,739
|
Year Ended 2/28/2021
|
$15.58
|
29.82%
|
1.91%
(d)
|
1.54%
(c),(d)
|
0.18%
|
64%
|
$7,703
|
Year Ended 2/29/2020
|
$12.92
|
6.45%
|
1.93%
|
1.55%
(c)
|
0.83%
|
46%
|
$6,040
|
Institutional Class
|
|||||||
Six Months Ended 8/31/2024 (Unaudited)
|
$21.56
|
11.61%
|
0.86%
|
0.61%
|
0.47%
|
29%
|
$359,348
|
Year Ended 2/29/2024
|
$19.92
|
32.29%
|
0.87%
|
0.58%
(c)
|
0.96%
|
61%
|
$328,278
|
Year Ended 2/28/2023
|
$15.83
|
(9.65%
)
|
0.88%
(d)
|
0.55%
(c),(d)
|
1.07%
|
55%
|
$261,568
|
Year Ended 2/28/2022
|
$18.63
|
17.28%
|
0.87%
(d)
|
0.54%
(c),(d)
|
0.79%
|
58%
|
$214,100
|
Year Ended 2/28/2021
|
$17.13
|
31.04%
|
0.91%
(d)
|
0.54%
(c),(d)
|
1.18%
|
64%
|
$169,476
|
Year Ended 2/29/2020
|
$14.10
|
7.54%
|
0.93%
|
0.55%
(c)
|
1.76%
|
46%
|
$125,623
|
Institutional 2 Class
|
|||||||
Six Months Ended 8/31/2024 (Unaudited)
|
$22.51
|
11.63%
|
0.80%
|
0.55%
|
0.53%
|
29%
|
$238,099
|
Year Ended 2/29/2024
|
$20.77
|
32.38%
|
0.81%
|
0.51%
|
1.03%
|
61%
|
$213,892
|
Year Ended 2/28/2023
|
$16.47
|
(9.64%
)
|
0.81%
(d)
|
0.48%
(d)
|
1.12%
|
55%
|
$184,917
|
Year Ended 2/28/2022
|
$19.35
|
17.45%
|
0.80%
(d)
|
0.47%
(d)
|
0.85%
|
58%
|
$198,955
|
Year Ended 2/28/2021
|
$17.73
|
31.20%
|
0.83%
(d)
|
0.46%
(d)
|
1.26%
|
64%
|
$102,131
|
Year Ended 2/29/2020
|
$14.55
|
7.61%
|
0.85%
|
0.46%
|
1.97%
|
46%
|
$22,676
|
|
Net asset value,
beginning of
period
|
Net
investment
income
(loss)
|
Net
realized
and
unrealized
gain (loss)
|
Total from
investment
operations
|
Distributions
from net
investment
income
|
Distributions
from net
realized
gains
|
Total
distributions to
shareholders
|
Institutional 3 Class
|
|||||||
Six Months Ended 8/31/2024 (Unaudited)
|
$19.52
|
0.06
|
2.20
|
2.26
|
(0.06
)
|
(0.60
)
|
(0.66
)
|
Year Ended 2/29/2024
|
$15.53
|
0.19
|
4.73
|
4.92
|
(0.20
)
|
(0.73
)
|
(0.93
)
|
Year Ended 2/28/2023
|
$18.30
|
0.19
|
(1.98
)
|
(1.79
)
|
(0.18
)
|
(0.80
)
|
(0.98
)
|
Year Ended 2/28/2022
|
$16.85
|
0.17
|
2.81
|
2.98
|
(0.22
)
|
(1.31
)
|
(1.53
)
|
Year Ended 2/28/2021
|
$13.88
|
0.20
|
3.98
|
4.18
|
(0.26
)
|
(0.95
)
|
(1.21
)
|
Year Ended 2/29/2020
|
$13.63
|
0.29
|
0.76
|
1.05
|
(0.18
)
|
(0.62
)
|
(0.80
)
|
Notes to Financial Highlights
|
|
(a)
|
In addition to the fees and expenses that the Fund bears directly, the Fund indirectly bears a pro rata share of the fees and expenses of any other funds in which it invests. Such indirect expenses are not included in the Fund's reported expense ratios.
|
(b)
|
Total net expenses include the impact of certain fee waivers/expense reimbursements made by the Investment Manager and certain of its affiliates, if applicable.
|
(c)
|
The benefits derived from expense reductions had an impact of less than 0.01%.
|
(d)
|
Ratios include interest on collateral expense which is less than 0.01%.
|
(e)
|
Rounds to zero.
|
|
Net
asset
value,
end of
period
|
Total
return
|
Total gross
expense
ratio to
average
net assets(a)
|
Total net
expense
ratio to
average
net assets(a),(b)
|
Net investment
income (loss)
ratio to
average
net assets
|
Portfolio
turnover
|
Net
assets,
end of
period
(000's)
|
Institutional 3 Class
|
|||||||
Six Months Ended 8/31/2024 (Unaudited)
|
$21.12
|
11.66%
|
0.75%
|
0.50%
|
0.58%
|
29%
|
$638,743
|
Year Ended 2/29/2024
|
$19.52
|
32.41%
|
0.76%
|
0.46%
|
1.07%
|
61%
|
$623,513
|
Year Ended 2/28/2023
|
$15.53
|
(9.54%
)
|
0.76%
(d)
|
0.43%
(d)
|
1.17%
|
55%
|
$559,371
|
Year Ended 2/28/2022
|
$18.30
|
17.40%
|
0.75%
(d)
|
0.42%
(d)
|
0.92%
|
58%
|
$700,548
|
Year Ended 2/28/2021
|
$16.85
|
31.26%
|
0.78%
(d)
|
0.41%
(d)
|
1.29%
|
64%
|
$724,055
|
Year Ended 2/29/2020
|
$13.88
|
7.72%
|
0.80%
|
0.42%
|
2.04%
|
46%
|
$364,432
|
|
Liability derivatives
|
|
Risk exposure
category
|
Statement
of assets and liabilities
location
|
Fair value ($)
|
Equity risk
|
Option contracts written, at value
|
124,325
|
Amount of realized gain (loss) on derivatives recognized in income
|
|
Risk exposure category
|
Option
contracts
written
($)
|
Equity risk
|
(956,648
)
|
|
|
Change in unrealized appreciation (depreciation) on derivatives recognized in income
|
|
Risk exposure category
|
Option
contracts
written
($)
|
Equity risk
|
118,193
|
Derivative instrument
|
Average
value ($)
|
Option contracts written
|
(124,937
)
|
|
Morgan
Stanley ($)
|
Liabilities
|
|
Call option contracts written
|
124,325
|
Total financial and derivative net assets
|
(124,325
)
|
Total collateral received (pledged) (a)
|
(124,325
)
|
Net amount (b)
|
-
|
(a)
|
In some instances, the actual collateral received and/or pledged may be more than the amount shown due to overcollateralization.
|
(b)
|
Represents the net amount due from/(to) counterparties in the event of default.
|
|
Effective rate (%)
|
Class A
|
0.12
|
Advisor Class
|
0.12
|
Class C
|
0.12
|
Institutional Class
|
0.12
|
Institutional 2 Class
|
0.06
|
Institutional 3 Class
|
0.01
|
|
Front End (%)
|
CDSC (%)
|
Amount ($)
|
Class A
|
5.75
|
0.50 - 1.00
(a)
|
55,505
|
Class C
|
-
|
1.00
(b)
|
122
|
(a)
|
This charge is imposed on certain investments of between $1 million and $50 million redeemed within 18 months after purchase, as follows: 1.00% if redeemed within 12 months after purchase, and 0.50% if redeemed more than 12, but less than 18, months after purchase, with certain limited exceptions.
|
(b)
|
This charge applies to redemptions within 12 months after purchase, with certain limited exceptions.
|
|
July 1, 2024
through
June 30, 2025 (%)
|
Prior to
July 1, 2024 (%)
|
Class A
|
0.90
|
0.85
|
Advisor Class
|
0.65
|
0.60
|
Class C
|
1.65
|
1.60
|
Institutional Class
|
0.65
|
0.60
|
Institutional 2 Class
|
0.59
|
0.53
|
Institutional 3 Class
|
0.54
|
0.48
|
Federal
tax cost ($)
|
Gross unrealized
appreciation ($)
|
Gross unrealized
(depreciation) ($)
|
Net unrealized
appreciation ($)
|
857,487,000
|
659,665,000
|
(922,000
)
|
658,743,000
|
Item 8. Changes in and Disagreements with Accountants for Open-End Management Investment Companies.
Not applicable.
Item 9. Proxy Disclosures for Open-End Management Investment Companies.
Not applicable.
Item 10. Remuneration Paid to Directors, Officers, and Others of Open-End Management Investment Companies.
Remuneration Paid to Directors, Officers, and Others of Open-End Management Investment Companies is included in Item 7 of this Form N-CSR.
Item 11. Statement Regarding Basis for Approval of Investment Advisory Contract.
Statement regarding basis for approval of Investment Advisory Contract is included in Item 7 of this Form N-CSR.
Item 12. Disclosure of Proxy Voting Policies and Procedures for Closed-End Management Investment Companies.
Not applicable.
Item 13. Portfolio Managers of Closed-End Management Investment Companies.
Not applicable.
Item 14. Purchases of Equity Securities by Closed-End Management Investment Company and Affiliated Purchasers.
Not applicable.
Item 15. Submission of Matters to a Vote of Security Holders.
There were no material changes to the procedures by which shareholders may recommend nominees to the registrant's board of directors implemented since the registrant last provided disclosure as to such procedures in response to the requirements of Item 407(c)(2)(iv) of Regulation S-K or Item 15 of Form N-CSR.
Item 16. Controls and Procedures.
(a) The registrant's principal executive officer and principal financial officer, based on their evaluation of the registrant's disclosure controls and procedures as of a date within 90 days of the filing of this report, have concluded that such controls and procedures are adequately designed to ensure that information required to be disclosed by the registrant in Form N-CSR is accumulated and communicated to the registrant's management, including the principal executive officer and principal financial officer, or persons performing similar functions, as appropriate to allow timely decisions regarding required disclosure.
(b) There was no change in the registrant's internal control over financial reporting that occurred during the period covered by this report that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting.
Item 17. Disclosure of Securities Lending Activities for Closed-End Management Investment Companies.
Not applicable.
Item 18. Recovery of Erroneously Awarded Compensation.
Not applicable.
Item 19. Exhibits.
(a)(1) Not applicable.
(a)(2) Certifications pursuant to Rule 30a-2(a) under the Investment Company Act of 1940 (17 CFR 270.30a-2(a)) attached hereto as Exhibit 99.CERT.
(b) Certification pursuant to Rule 30a-2(b) under the Investment Company Act of 1940 (17 CFR 270.30a-2(b)) attached hereto as Exhibit 99.906CERT.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934 and the Investment Company Act of 1940, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
(registrant) | Columbia Funds Series Trust |
|
|
By (Signature and Title) | /s/ Daniel J. Beckman |
Daniel J. Beckman, President and Principal Executive Officer | |
|
|
Date | October 23, 2024 |
Pursuant to the requirements of the Securities Exchange Act of 1934 and the Investment Company Act of 1940, this report has been signed below by the following persons on behalf of the registrant and in the capacities and on the dates indicated.
By (Signature and Title) | /s/ Daniel J. Beckman |
Daniel J. Beckman, President and Principal Executive Officer | |
|
|
Date | October 23, 2024 |
|
|
By (Signature and Title) | /s/ Michael G. Clarke |
Michael G. Clarke, Chief Financial Officer, | |
Principal Financial Officer and Senior Vice President | |
|
|
Date | October 23, 2024 |
|
|
By (Signature and Title) | /s/ Charles H. Chiesa |
Charles H. Chiesa, Treasurer, Chief Accounting | |
Officer and Principal Financial Officer | |
|
|
Date | October 23, 2024 |